238 related articles for article (PubMed ID: 7333059)
1. Pharmacokinetics of metoprolol in patients with hepatic cirrhosis.
Regårdh CG; Jordö L; Ervik M; Lundborg P; Olsson R; Rönn O
Clin Pharmacokinet; 1981; 6(5):375-88. PubMed ID: 7333059
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and pharmacodynamic properties of metoprolol in patients with impaired renal function.
Jordö L; Attman PO; Aurell M; Johansson L; Johnsson G; Regårdh CG
Clin Pharmacokinet; 1980; 5(2):169-80. PubMed ID: 6102500
[TBL] [Abstract][Full Text] [Related]
3. The effect of impaired renal function on the plasma concentration and urinary excretion of metoprolol metabolites.
Hoffmann KJ; Regårdh CG; Aurell M; Ervik M; Jordö L
Clin Pharmacokinet; 1980; 5(2):181-91. PubMed ID: 7363533
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics of metoprolol and its metabolites in dialysis patients.
Seiler KU; Schuster KJ; Meyer GJ; Niedermayer W; Wassermann O
Clin Pharmacokinet; 1980; 5(2):192-8. PubMed ID: 7363534
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of metoprolol and its metabolite alpha-OH-metoprolol in healthy, non-smoking, elderly individuals.
Regårdh CG; Landahl S; Larsson M; Lundborg P; Steen B; Hoffmann KJ; Lagerström PO
Eur J Clin Pharmacol; 1983; 24(2):221-6. PubMed ID: 6840171
[TBL] [Abstract][Full Text] [Related]
6. The effect of pretreatment with cimetidine on the bioavailability and disposition of atenolol and metoprolol.
Houtzagers JJ; Streurman O; Regårdh CG
Br J Clin Pharmacol; 1982 Jul; 14(1):67-72. PubMed ID: 6125199
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability and disposition of metoprolol and hydrochlorothiazide combined in one tablet and of separate doses of hydrochlorothiazide.
Jordö L; Johnsson G; Lundborg P; Persson BA; Regärdh CG; Rönn O
Br J Clin Pharmacol; 1979 Jun; 7(6):563-7. PubMed ID: 465277
[TBL] [Abstract][Full Text] [Related]
8. Increased oral clearance of metoprolol in pregnancy.
Högstedt S; Lindberg B; Rane A
Eur J Clin Pharmacol; 1983; 24(2):217-20. PubMed ID: 6840170
[TBL] [Abstract][Full Text] [Related]
9. Metoprolol kinetics and dose response in hypertensive patients.
Myers MG; Thiessen JJ
Clin Pharmacol Ther; 1980 Jun; 27(6):756-62. PubMed ID: 7379442
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of [14C]omeprazole in patients with liver cirrhosis.
Andersson T; Olsson R; Regårdh CG; Skånberg I
Clin Pharmacokinet; 1993 Jan; 24(1):71-8. PubMed ID: 8448974
[TBL] [Abstract][Full Text] [Related]
11. Cimetidine clearance and bioavailability in hepatic cirrhosis.
Sonne J; Poulsen HE; Døssing M; Larsen NE; Andreasen PB
Clin Pharmacol Ther; 1981 Feb; 29(2):191-7. PubMed ID: 7460483
[TBL] [Abstract][Full Text] [Related]
12. Cefoperazone pharmacokinetics in patients with liver cirrhosis: a predictive value of the ujoviridin test.
Saudek F; Morávek J; Modr Z
Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):82-7. PubMed ID: 2921099
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of bisoprolol during repeated oral administration to healthy volunteers and patients with kidney or liver disease.
Kirch W; Rose I; Demers HG; Leopold G; Pabst J; Ohnhaus EE
Clin Pharmacokinet; 1987 Aug; 13(2):110-7. PubMed ID: 2887325
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with atenolol in patients with chronic liver disease.
Kirch W; Schäfer-Korting M; Mutschler E; Ohnhaus EE; Braun W
J Clin Pharmacol; 1983 Apr; 23(4):171-7. PubMed ID: 6863581
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of midazolam following intravenous and oral administration in patients with chronic liver disease and in healthy subjects.
Pentikäinen PJ; Välisalmi L; Himberg JJ; Crevoisier C
J Clin Pharmacol; 1989 Mar; 29(3):272-7. PubMed ID: 2723115
[TBL] [Abstract][Full Text] [Related]
16. Influence of inflammatory disease on the clinical pharmacokinetics of atenolol and metoprolol.
Kirch W; Spahn H; Ohnhaus EE; Köhler H; Heinz U; Mutschler E
Biopharm Drug Dispos; 1983; 4(1):73-81. PubMed ID: 6839004
[TBL] [Abstract][Full Text] [Related]
17. Effect of rifampicin on metoprolol and antipyrine kinetics.
Bennett PN; John VA; Whitmarsh VB
Br J Clin Pharmacol; 1982 Mar; 13(3):387-91. PubMed ID: 7059439
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of CYP2D6 by quinidine and its effects on the metabolism of cilostazol.
Bramer SL; Suri A
Clin Pharmacokinet; 1999; 37 Suppl 2():41-51. PubMed ID: 10702886
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of cimetidine in advanced cirrhosis.
Grahnén A; Jameson S; Lööf L; Tyllström J; Lindström B
Eur J Clin Pharmacol; 1984; 26(3):347-55. PubMed ID: 6734697
[TBL] [Abstract][Full Text] [Related]
20. Basic pharmacokinetics of bisoprolol, a new highly beta 1-selective adrenoceptor antagonist.
Leopold G; Pabst J; Ungethüm W; Bühring KU
J Clin Pharmacol; 1986; 26(8):616-21. PubMed ID: 2878941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
